Elective Generator Replacement of the Subcutaneous Implantable Defibrillator—Always a Simple Pit Stop?

Background and Aims: The safety and efficacy of the subcutaneous implantable cardioverter‐defibrillator (S‐ICD) has been proven in various clinical trials. Data on device replacement strategies is scarce. This study aims to evaluate long‐term shock efficacy, trends in shock impedance, and the effect...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Cardiovascular Electrophysiology Vol. 36; no. 5; pp. 1053 - 1061
Autores principales: Fastenrath, Fabian, Wuerfel, Sara, Liebe, Volker, Akin, Ibrahim, Duerschmied, Daniel, Borggrefe, Martin, Kuschyk, Juergen, Rudic, Boris
Formato: pictorial research tables/charts Journal Article
Publicado: Wiley-Blackwell May2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=185153666&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 185153666
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10453873
        GSB
      jtl: Journal of Cardiovascular Electrophysiology
      issn: 10453873
      maglogo: Y
    pubinfo:
      dt: May2025
      vid: 36
      iid: 5
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        185153666
        183837549
        185153666
        185153666
        10.1111/jce.16638
        185153666
      ppf: 1053
      ppct: 8
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Elective Generator Replacement of the Subcutaneous Implantable Defibrillator—Always a Simple Pit Stop?
      aug:
        au:
          Fastenrath, Fabian
          Wuerfel, Sara
          Liebe, Volker
          Akin, Ibrahim
          Duerschmied, Daniel
          Borggrefe, Martin
          Kuschyk, Juergen
          Rudic, Boris
        affil: Cardiology, Angiology, Haemostaseology, and Medical Intensive Care, Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
      sug:
        subj:
          Defibrillators, Implantable Methods
          Pacemaker, Artificial
          Device Removal Statistics and Numerical Data
          Heart Failure Therapy
          Treatment Outcomes
          Human
          Male
          Female
          Descriptive Statistics
          Electric Impedance
          Chi Square Test
          Fisher's Exact Test
          T-Tests
          Mann-Whitney U Test
          Wilcoxon Signed Rank Test
          Data Analysis Software
          Adult
          Middle Age
          Aged
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Aged: 65+ years
          Male
          Female
      ab: Background and Aims: The safety and efficacy of the subcutaneous implantable cardioverter‐defibrillator (S‐ICD) has been proven in various clinical trials. Data on device replacement strategies is scarce. This study aims to evaluate long‐term shock efficacy, trends in shock impedance, and the effects of a replacement strategy at elective device replacement. Methods: Between January 2018 and November 2022, a total of 99 consecutive patients underwent S‐ICD device replacement. Shock impedance was determined at initial implantation, before and after device replacement. In case of high shock impedance, additional optimization of lead and generator position was performed if applicable, as well as the removal of fibrous encapsulation ("capsulectomy") of the S‐ICD pocket. Results: Defibrillation testing with the first 65 J shock was successful in 87% of patients after initial device implantation versus 85% with the same device immediately before device replacement (p = 0.88). Eight patients preoperatively failed defibrillation testing with 65 J and 80 J. After a mean dwell time of 65 ± 21 months, shock impedance increased significantly from 82 ± 23 Ω at initial implantation to 98 ± 37 Ω at replacement (p = 0.004). Capsulectomy and optimized repositioning of the S‐ICD lead and generator resulted in a significant decrease of shock impedance to 81 ± 25 Ω as compared to 98 ± 37 Ω before the replacement (p = 0.004). 65 J shock efficacy improved to 95%. Postoperative defibrillation testing was successful in all patients. No acute complications were observed. Conclusion: High conversion rates at device replacement are achievable through optimized replacement strategy. In addition to improving the lead and generator position, capsulectomy appears to be a safe and effective way to reduce shock impedance and might contribute to overall system performance.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N